Toxins an Open Access Journal by MDPI

Total Page：16

File Type：pdf, Size：1020Kb

IMPACT Indexed in: FACTOR PubMed 4.546 toxins an Open Access Journal by MDPI The French Society on Toxinology (SFET), International Academic Open Access Publishing Society for Mycotoxicology (ISM), Japanese Society of since 1996 Mycotoxicology (JSMYCO) and European Uremic Toxins (EUTox) Work Group are affiliated with Toxins IMPACT Indexed in: FACTOR PubMed toxins 4.546 an Open Access Journal by MDPI Editor-in-Chief Message from the Editor-in-Chief Prof. Dr. Jay Fox Toxinology is an incredibly diverse area of study, ranging from field surveys of environmental toxins to the study of Setion Editors-in-Chief Prof. Dr. Bryan Grieg Fry toxin action at the molecular level. The editorial board and Prof. Dr. Michel R. Popoff staff of Toxins are dedicated to providing a timely, peer- Dr. Nilgun E. Tumer reviewed outlet for exciting, innovative primary research Prof. Dr. R. Vanholder Prof. Dr. Sarah De Saeger articles and concise, informative reviews from investigators Prof. Dr. Vítor Vasconcelos in the myriad of disciplines contributing to our knowledge on toxins. We are committed to meeting the needs of the toxin research community by offering useful and timely reviews of all manuscripts submitted. Please consider Toxins when submitting your work for publication. Author Benefits Open Access Unlimited and free access for readers No Copyright Constraints Retain copyright of your work and free use of your article Thorough peer review Coverage by Leading Indexing Services SCIE-Science Citation Index Expanded (Clarivate Analytics, formerly Thomson Reuters), INSPEC (IET), Scopus (Elsevier) No Space Constraints, No Extra Space or Color Charges No restriction on the length of the papers, number of figures or colors Discounts on Article Processing Charges (APC) If you belong to an institute that participates with the MDPI Institutional Open Access Program (IOAP) Impact Factor 4.546 (2020 Journal Citation Reports®), 5-Year Impact Factor: 4.800 (2020) Fast Manuscript Handling Time Manuscripts are peer-reviewed and a first decision provided to authors approximately 15.7 days after submission; acceptance to publication is undertaken in 2.8 days (median values for papers published in this journal in the first half of 2021) Aims and Scope Toxins (ISSN 2072-6651) is an international, open access journal that provides an advanced forum for studies re- lated to toxins and toxinology. We aim at publishing high quality manuscripts that report new investigations into all aspects of research on natural toxins. It publishes reviews, regular research papers and short communications. All submitted manuscripts undergo rigorous double-blind peer review prior to publication. According to the Journal Citation Reports®, published in June 2020, the Impact Factor of Toxins is 4.546, 5-year Impact Factor is 4.800. The journal now ranks 21/93 (Q1) in ‘Toxicology’ and 32/144 (Q1) in ‘Food Science & Technology’ category. The CiteScore (Scopus) of Toxins in 2020 is 5.5, ranks Q1 (33/134) in the category of ‘Health, Toxicology and Mutagenesis’, and Q2 (35/122) in the category of ‘Toxicology’. Animal Venoms Plant Toxins Uremic Toxins Freshwater and Marine Toxins Bacterial Toxins Mycotoxins Editorial Office Toxins Editorial Office [email protected] MDPI, St. Alban-Anlage 66 4052 Basel, Switzerland Tel: +41 61 683 77 34 Fax: +41 61 302 89 18 www.mdpi.com mdpi.com/journal/toxins MDPI is a member of Affiliated Societies Follow Us facebook.com/MDPIOpenAccessPublishing twitter.com/MDPIOpenAccess linkedin.com/company/mdpi weibo.com/mdpicn Wechat: MDPI-China blog.mdpi.com www.mdpi.com mdpi.com/journal/toxins See www.mdpi.com for a full list of offices and contact information. MDPI is a company registered in Basel, Switzerland, No. CH-270.3.014.334-3, whose registered office is at St. Alban-Anlage 66, CH-4052 Basel, Switzerland. Basel, July 2021.

Copy Link

Recommended publications

TOXICOLOGY in VITRO Official Journal of the European Society of Toxicology in Vitro
TOXICOLOGY IN VITRO Official Journal of the European Society of Toxicology in Vitro AUTHOR INFORMATION PACK TABLE OF CONTENTS XXX . • Description p.1 • Audience p.2 • Impact Factor p.2 • Abstracting and Indexing p.2 • Editorial Board p.2 • Guide for Authors p.4 ISSN: 0887-2333 DESCRIPTION . Toxicology in Vitro publishes original research papers, reviews and workshop reports focusing on the application and use of in vitro and in silico systems for toxicological evaluations (collectively described as New Approach Methodologies (NAM)). This includes the utilisation or the development of NAMs for assessing the potential adverse effects of chemicals for human safety assessment. In vitro techniques include primary cells, tissue slices, cell lines and stem cells (adult, embryonic and induced Pluripotent cells) or subcellular preparations thereof. Our journal strongly supports the Reduction, Refinement and Replacement (3R) of animals in toxicology evaluations. This is a wide topic and thus we have certain preferences including: Development of in vitro techniques and their application to research and regulatory use (i.e. 3R principle. Mechanistic underpinning of data. Ability to translate outcome to human safety assessment.We strongly encourage : The use of normal (non-transformed) human cells (where appropriate). Reporting the Short Tandem Repeat (STR) profile of the cells used (especially when cells have been provided as a gift or generated in house). Free access to raw (or primary) data. Appropriate model characterisation. The use (or reduction) of animal free components, including serum. [Especially when the system was already developed under such conditions, such as the HK-2 cell line]. Attention to detailed methodology and appropriate statistics.
[Show full text]
The First Brazilian Electronic Scientific Publication Turns 20 Years Old Benedito Barraviera
Barraviera Journal of Venomous Animals and Toxins including Tropical Diseases (2015) 21:52 DOI 10.1186/s40409-015-0050-7 EDITORIAL Open Access CEVAP Journal: the first Brazilian electronic scientific publication turns 20 years old Benedito Barraviera The year 2015 marks 350 years since the appearance of to the Vancouver Group, any electronic publication made the world’s first scientific publication and 20 years since available on the Internet constitutes a publication [7]. the publication of the Journal of Venomous Animals In 1995, there were about 100 electronic journals in and Toxins including Tropical Diseases (JVATiTD – the world, and the commercial Internet was starting in www.jvat.org) [1–3]. It was the first Brazilian electronic Brazil. In this context, the first Brazilian electronic scien- scientific publication – an official journal of the Center tific journal was launched in Botucatu, covering the area for the Study of Venoms and Venomous Animals of Toxinology. This new journal started one hundred (CEVAP) of São Paulo State University (UNESP) [4]. years after Vital Brazil lived in Botucatu. It is a homage The printing-press revolution, one of the most im- we paid to this brilliant Brazilian scientist [4]. The Journal portant breakthroughs for humanity, began about 1465 of Venomous Animals and Toxins (JVAT) circulated until when Johannes Gutenberg invented a moveable mech- 2002. Between 1995 and 1999, it was distributed on floppy anical type for printing. In 1665, the first scientific jour- disks, between 2000 and 2002 on CD-ROM, and only nals appeared in France and England, called respectively from 2003 on by the Internet, initially via the website the Journal des Sçavans and Philosophical Transactions.
[Show full text]
TOXICOLOGY Affiliated with the German Toxicology Society
TOXICOLOGY Affiliated with the German Toxicology Society AUTHOR INFORMATION PACK TABLE OF CONTENTS XXX . • Description p.1 • Audience p.2 • Impact Factor p.2 • Abstracting and Indexing p.2 • Editorial Board p.2 • Guide for Authors p.4 ISSN: 0300-483X DESCRIPTION . Toxicology as a multidisciplinary, data-rich field has witnessed the availability of a cutting-edge technologies to investigate mechanisms underlying adverse consequences of exposures to xenobiotic chemicals, particularly as it relates to human health. Toxicology fully embraces these advancements by serving as a hub for exchange of information regarding state-of-the-art developments in the broad field of contemporary toxicology. Journal scope emphasis is on human-relevant and mechanistic research at all levels of biological organization, ranging from the molecular scale to the organismal level. The publication priority for Toxicology is on original high-quality research and review papers on any topic relevant to toxicology, in particular related to hazard identification, all that are subject to rigorous peer-review. The Toxicology target audience includes undergraduates to full professionals in academic, industrial and regulatory settings in any part of the world. Notes from the Editors In order to support interpretation of published findings to human health, the journal requires inclusion of specific statements within the ABSTRACT and METHODS sections of each submitted article: ABSTRACT: The experimental system (e.g., in vivo species, cell culture, etc.) including the exposure dose or concentration and duration that produces an effect, if an effect is observed, must be described in the ABSTRACT to the manuscript.MATERIALS AND METHODS: The relevance of the experimental system and exposure dose or concentration and duration in terms of potential human exposures must be described in the Materials and Methods section of the manuscript.
[Show full text]
A Bibliometric Analysis of Toxicology Research
Zyoud et al. Health Research Policy and Systems 2014, 12:4 http://www.health-policy-systems.com/content/12/1/4 RESEARCH Open Access A bibliometric analysis of toxicology research productivity in Middle Eastern Arab countries during a 10-year period (2003–2012) Sa’ed H Zyoud1,2,3*, Samah W Al-Jabi4, Waleed M Sweileh2 and Rahmat Awang3 Abstract Background: Bibliometric studies are increasingly being used for research assessment by involving the application of statistical methods to scientific publications to obtain the bibliographics for each country. The main objective of this study was to analyse the research productivity originating from 13 Middle Eastern Arab (MEA) countries with articles published in toxicology journals. Methods: Data from January 1, 2003 till December 31, 2012 were searched for documents with specific words in the toxicology field as a “source title” in any one of the 13 MEA countries. Research productivity was evaluated based on a methodology developed and used in other bibliometric studies. Research productivity was adjusted to the national population and nominal gross domestic product (GDP) per capita. Results: Documents (n = 1,240) were retrieved from 73 international peer-reviewed toxicology journals. The h-index of the retrieved documents was 39. Of the 73 journal titles, 52 (69.9%) have their IF listed in the ISI Journal Citation Reports 2012; 198 documents (16.0%) were published in journals that had no official IF. After adjusting for economy and population power, Egypt (193.6), Palestine (18.1), Kingdom of Saudi Arabia (KSA) (13.0), and Jordan (11.5) had the highest research productivity.
[Show full text]
Food and Chemical Toxicology
FOOD AND CHEMICAL TOXICOLOGY AUTHOR INFORMATION PACK TABLE OF CONTENTS XXX . • Description p.1 • Audience p.2 • Impact Factor p.2 • Abstracting and Indexing p.2 • Editorial Board p.2 • Guide for Authors p.5 ISSN: 0278-6915 DESCRIPTION . Food and Chemical Toxicology (FCT), an internationally renowned journal, that publishes original research articles and reviews on toxic effects, in animals and humans, of natural or synthetic chemicals occurring in the human environment with particular emphasis on food, drugs, and chemicals, including agricultural and industrial safety, and consumer product safety. Areas such as safety evaluation of novel foods and ingredients, biotechnologically-derived products, and nanomaterials are included in the scope of the journal. FCT also encourages submission of papers on inter-relationships between nutrition and toxicology and on in vitro techniques, particularly those fostering the 3 Rs. The principal aim of the journal is to publish high impact, scholarly work and to serve as a multidisciplinary forum for research in toxicology. Papers submitted will be judged on the basis of scientific originality and contribution to the field, quality and subject matter. Studies should address at least one of the following: Adverse physiological/biochemical, or pathological changes induced by specific defined substances New techniques for assessing potential toxicity, including molecular biology Mechanisms underlying toxic phenomena Toxicological examinations of specific chemicals or consumer products, both those showing adverse effects and those demonstrating safety, that meet current standards of scientific acceptability Authors must clearly and briefly identify what novel toxic effect (s) or toxic mechanism (s) of the chemical are being reported and what their significance is in the abstract.
[Show full text]
Regulatory Toxicology and Pharmacology
REGULATORY TOXICOLOGY AND PHARMACOLOGY AUTHOR INFORMATION PACK TABLE OF CONTENTS XXX . • Description p.1 • Impact Factor p.1 • Abstracting and Indexing p.2 • Editorial Board p.2 • Guide for Authors p.4 ISSN: 0273-2300 DESCRIPTION . Regulatory Toxicology and Pharmacology publishes peer reviewed articles that involve the generation, evaluation, and interpretation of experimental animal and human data that are of direct importance and relevance for regulatory authorities with respect to toxicological and pharmacological regulations in society. All peer-reviewed articles that are published should be devoted to improve the protection of human health and environment. Reviews and discussions are welcomed that address legal and/or regulatory decisions with respect to risk assessment and management of toxicological and pharmacological compounds on a scientific basis. It addresses an international readership of scientists, risk assessors and managers, and other professionals active in the field of human and environmental health. Types of peer-reviewed articles published: Original research articles of relevance for regulatory aspects covering aspects including, but not limited to: Factors influencing human sensitivity Exposure science related to risk assessment Alternative toxicological test methods Frameworks for evaluation and integration of data in regulatory evaluations Harmonization across regulatory agencies Read-across methods and evaluations Contemporary Reviews on policy related Research issues Letters to the Editor Guest Editorials (by Invitation) News on recent or upcoming policy related Research issues, outcomes of regulatory expert meetings with implications for risk assessment and management RTP Tobacco policy Regulatory Toxicology and Pharmacology, as the journal serving developments for improvement of human health and environment, will not consider manuscripts that have been supported by tobacco companies.
[Show full text]
TOXICON an Interdisciplinary Journal on the Toxins Derived from Animals, Plants and Microorganisms
TOXICON An Interdisciplinary Journal on the Toxins Derived from Animals, Plants and Microorganisms AUTHOR INFORMATION PACK TABLE OF CONTENTS XXX . • Description p.1 • Audience p.2 • Impact Factor p.2 • Abstracting and Indexing p.2 • Editorial Board p.3 • Guide for Authors p.6 ISSN: 0041-0101 DESCRIPTION . Toxicon has an open access mirror Toxicon: X which has the same aims and scope, editorial board and peer-review process. To submit to Toxicon: X visit https://www.editorialmanager.com/TOXCX/default.aspx. An introductory offer Toxicon: X - full waiver of the Open Access fee. Toxicon's "aims and scope" are to publish: articles containing the results of original research on problems related to toxins derived from animals, plants and microorganisms papers on novel findings related to the chemical, pharmacological, toxicological, and immunological properties of natural toxinsmolecular biological studies of toxins and other genes from poisonous and venomous organisms that advance understanding of the role or function of toxins clinical observations on poisoning and envenoming where a new therapeutic principle has been proposed or a decidedly superior clinical result has been obtained. material on the use of toxins as tools in studying biological processes and material on subjects related to venom and antivenom problems. articles on the translational application of toxins, for example as drugs and insecticides epidemiological studies on envenoming or poisoning, so long as they highlight a previously unrecognised medical problem or provide insight into the prevention or medical treatment of envenoming or poisoning. Retrospective surveys of hospital records, especially those lacking species identification, will not be considered for publication.
[Show full text]
Evaluating Journal Impact Factor: a Systematic Survey of the Pros and Cons, and Overview of Alternative Measures
RESEARCH OPEN ACCESS ISSN 1678-9199 www.jvat.org Evaluating Journal Impact Factor: a systematic survey of the pros and cons, and overview of alternative measures Eugene Mech1,2, Muhammad Muneeb Ahmed2,3 , Edward Tamale2, Matthew Holek2, Guowei Li2,4, Lehana Thabane2,5,6,7,8,9,* 1 Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, Canada. 2 Department of Health Research Methods, Evidence, and Impact (HEI), McMaster University, Hamilton, ON, Canada. 3 Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada. 4 Center for Clinical Epidemiology and Methodology (CCEM), Guangdong Second Provincial General Hospital, China. 5 Biostatistics Unit, Research Institute at St Joseph’s Healthcare, Hamilton, ON, Canada. 6 Department of Anesthesia, McMaster University, Hamilton, ON, Canada. 7 Department of Pediatrics, McMaster University, Hamilton, ON, Canada. 8 School of Nursing, McMaster University, Hamilton, ON, Canada. 9 School of Rehabilitation Science, McMaster University, Hamilton, ON, Canada. Keywords: Abstract Journal Impact Factor Background: Journal Impact Factor (JIF) has several intrinsic flaws, which highlight Bibliometrics its inability to adequately measure citation distributions or indicate journal quality. Alternative metrics Despite these flaws, JIF is still widely used within the academic community, resulting Citations and impact in the propagation of potentially misleading information. A critical review of the usefulness of JIF is needed including an overview of the literature to identify viable alternative metrics. The objectives of this study are: (1) to assess the usefulness of JIF by compiling and comparing its advantages and disadvantages; (2) to record the differential uses of JIF within research environments; and (3) to summarize and compare viable alternative measures to JIF.
[Show full text]
Literature Search for Drug Safety: Process Model
Literature Search for Drug Safety: Process Model 1. Identify the drug. 2. Check for alternate names of the drug. Using Micromedex, type in the drug name. From the Integrated Index, click on Summary Documents and under Drug Information, click on links that might say “List of Drugdex Tradename Products” or “List of Martindale Tradename Products”. Martindale is especially good for foreign drug names. 3. Define the research setting and population in which the drug will be used. 4. Consult reference or tertiary sources as a starting point. Tertiary sources are usually summaries of available information in an understandable format (reference sourcebooks, textbooks). 5. Consult secondary sources for comprehensiveness and quality assurance. Secondary sources are databases that index or abstract the primary literature (bibliographies, reviews, indexing and abstracting services). Primary sources are patents, conference papers, case reports, journal articles, correspondence, and theses. 6. Choose the most appropriate sources of evidence of safety/adverse effects. 7. Create bibliography. Attached: Reference/Tertiary Drug Information Sources Secondary Sources for Drug and Chemical Information Reference/Tertiary Drug Information Sources These are examples of reference/tertiary drug information sources. Check the online catalog and Ref 17 for more. Title Description Citation EResource PResource Drug information: a Detailed and annotated guide to drug Snow, Bonnie. Drug No guide to current and chemical information, including Information: A Guide to resources history, legislation, and industry Current Resources, 2nd Ref 2 ZRS91 S64 1999 information. edition. Lanham, MD: Medical Library Association and Scarecrow Press, 1999. AHFS drug A tested and proven source of AHFS drug information. Yes information 2003 comparative, unbiased, and evaluative Bethesda, MD : Published drug information containing a by authority of the Board of Click EBooks on home page.
[Show full text]
Journal List of Scopus.Xlsx
Sourcerecord id Source Title (CSA excl.) (Medline-sourced journals are indicated in Green). Print-ISSN Including Conference Proceedings available in the scopus.com Source Browse list 16400154734 A + U-Architecture and Urbanism 03899160 5700161051 A Contrario. Revue interdisciplinaire de sciences sociales 16607880 19600162043 A.M.A. American Journal of Diseases of Children 00968994 19400157806 A.M.A. archives of dermatology 00965359 19600162081 A.M.A. Archives of Dermatology and Syphilology 00965979 19400157807 A.M.A. archives of industrial health 05673933 19600162082 A.M.A. Archives of Industrial Hygiene and Occupational Medicine 00966703 19400157808 A.M.A. archives of internal medicine 08882479 19400158171 A.M.A. archives of neurology 03758540 19400157809 A.M.A. archives of neurology and psychiatry 00966886 19400157810 A.M.A. archives of ophthalmology 00966339 19400157811 A.M.A. archives of otolaryngology 00966894 19400157812 A.M.A. archives of pathology 00966711 19400157813 A.M.A. archives of surgery 00966908 5800207606 AAA, Arbeiten aus Anglistik und Amerikanistik 01715410 28033 AAC: Augmentative and Alternative Communication 07434618 50013 AACE International. Transactions of the Annual Meeting 15287106 19300156808 AACL Bioflux 18448143 4700152443 AACN Advanced Critical Care 15597768 26408 AACN clinical issues 10790713 51879 AACN clinical issues in critical care nursing 10467467 26729 AANA Journal 00946354 66438 AANNT journal / the American Association of Nephrology Nurses and Technicians 07441479 5100155055 AAO Journal 27096 AAOHN
[Show full text]
Toxicology and Applied Pharmacology
TOXICOLOGY AND APPLIED PHARMACOLOGY AUTHOR INFORMATION PACK TABLE OF CONTENTS XXX . • Description p.1 • Audience p.1 • Impact Factor p.1 • Abstracting and Indexing p.2 • Editorial Board p.2 • Guide for Authors p.6 ISSN: 0041-008X DESCRIPTION . Toxicology and Applied Pharmacology publishes original scientific research of relevance to animals or humans pertaining to the action of chemicals, drugs, or chemically-defined natural products. Regular articles address mechanistic approaches to physiological, pharmacologic, biochemical, cellular, or molecular understanding of toxicologic/pathologic lesions and to methods used to describe these responses. Safety Science articles address outstanding state-of- the-art preclinical and human translational characterization of drug and chemical safety employing cutting-edge science. Highly significant Regulatory Safety Science articles will also be considered in this category. Papers concerned with alternatives to the use of experimental animals are encouraged. Short articles report on high impact studies of broad interest to readers of TAAP that would benefit from rapid publication. These articles should contain no more than a combined total of four figures and tables. Authors should include in their cover letter the justification for consideration of their manuscript as a short article. TAAP also issues a standing call for outstanding Invited Review Articles. Potential authors should contact the Editor-In-Chief and complete an Invited Review Proposal Form before preparing or submitting their Review Article. Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services . Please see our Guide for Authors for information on article submission.
[Show full text]
COMPARATIVE BIOCHEMISTRY and PHYSIOLOGY - PART C: TOXICOLOGY & PHARMACOLOGY an International Journal
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY - PART C: TOXICOLOGY & PHARMACOLOGY An International Journal AUTHOR INFORMATION PACK TABLE OF CONTENTS XXX . • Description p.1 • Audience p.2 • Impact Factor p.2 • Abstracting and Indexing p.2 • Editorial Board p.2 • Guide for Authors p.7 ISSN: 1532-0456 DESCRIPTION . Comparative Biochemistry & Physiology (CBP) publishes papers in comparative, environmental and evolutionary physiology. Part C: Toxicology and Pharmacology (CBPC), focuses on toxicological mechanisms at different levels of organization, primarily chemical and drug action, biotransformation of xenobiotics, endocrine disruptors, nanoparticles, pharmaceuticals, and natural products chemistry. Most studies employ a molecular approach in combination with observations of higher levels of organization to assess the mechanism by which xenobiotics affect physiology. Analytical verification of exposure concentrations is strongly recommended for manuscripts reporting toxicological studies. All four CBP journals support and follow the editorial direction from all the major societies in the field: Australia & New Zealand Society of Comparative Physiology and Biochemistry (ANZSCPB) American Physiological Society (APS) Canadian Society of Zoologists (CSZ) Deutsche Zoologische Gesellschaft (DZG) European Society of Comparative Physiology and Biochemistry (ESCPB) Japanese Society for Comparative Physiology and Biochemistry (JSCPB) South American Society for Comparative Physiology and Biochemistry (SASCPB) Societe de Physiologie (SDP) Society for Experimental Biology (SEB) Society for Integrative & Comparative Biology (SICB) Benefits to authors CBP journals are focused on promoting the authors and the work published in the journal: All articles are carefully evaluated directly by the Editors-in-Chief who are leading experts in their field. Availability: contact the Editor-in-Chief via the Editorial Board page for any questions you may have.
[Show full text]